Rationale: NR4A1 (Nur77) is a nuclear receptor that is expressed in macrophages and within atherosclerotic lesions, yet its function in atherosclerosis is unknown.
N ur77 is an orphan nuclear receptor that, along with Nurr1 and NOR-1, are members of the orphan nuclear receptor subfamily 4A within the steroid/thyroid receptor family. 1 They are designated as "orphans" because their ligands are currently unknown. There is some question as to whether these nuclear receptors actually bind ligand, as all 3 receptors appear to have a closed ligand-binding pocket. 2 This has led some to postulate that these receptors are solely regulated in a ligand-independent fashion either transcriptionally or posttranslationally, by kinases and phosphatases. 1, 3 All 3 NR4A family members are expressed within atherosclerotic lesions. 4 In macrophages, all 3 family members have been identified, and appear to be induced rapidly by multiple stimuli, including lipopolysaccharide (LPS), tumor necrosis factor (TNF)␣, and oxidized LDL. 5 Induction of NR4A nuclear receptors leads to rapid induction of transcription of a host of anti-inflammatory genes. 1, 3, 6 These findings have led to the hypothesis that these nuclear receptors act to resolve inflammation. 5 Recently, Nurr1 has been shown to serve as a repressor of NFB activation in microglia and astrocytes. 7 NOR-1 deficiency has been shown to inhibit vascular injury and atherosclerosis in mice. 8, 9 However, the contribution of Nur77 to atherosclerosis development has not yet been reported, although de Vries et al 6 reported that Nur77 agonism inhibited vascular injury.
Monocytes serve as a first line of defense in innate and adaptive immune reactions. They are rapidly recruited to sites of injury or inflammation, where, after differentiation, they can present antigen to T lymphocytes 10 and secrete cytokines. [11] [12] [13] As critical as monocytes are to respond and resolve inflammation, they are also critically involved in mediating chronic diseases, such as atherosclerosis and rheumatoid arthritis. Counterparts to human monocyte subsets have been identified in mice. 11, 14, 15 Two primary monocyte subsets in mice have now been well characterized. One subset is termed as "inflammatory" and the other subset is considered as "surveillance" or "resident." The inflammatory monocytes are Ly6C ϩ CCR2 ϩ CX3CR1 lo CD62L ϩ and are selectively recruited to inflamed tissues and lymph nodes. 10, 16 The Ly6C ϩ inflammatory monocyte subset has been shown to egress from the bone marrow within hours of a bacterial infection in mice, and is CCR2-dependent. 14,16 -19 The second monocyte subset is characterized as Ly6C Ϫ CCR2 Ϫ CX3CR1 hi CD62L Ϫ . The Ly6C Ϫ monocytes patrol the endothelium of blood vessels but may not readily migrate in response to inflammation, except during tissue injury. 20 Several groups have demonstrated that both populations of monocytes are recruited to inflammation or injury sites. 20 -22 Both Ly6C ϩ monocytes 23 and Ly6C
Ϫ monocytes 22 can also participate in the resolution of inflammation and tissue repair.
Nurr1 and NOR-1 have been shown to participate in homeostasis of myeloid progenitors. 24 We recently reported that Nur77 drives expression of the Ly6C Ϫ monocyte subset through regulation of differentiation from a myeloid dendritic precursor. 25 Mice deficient in Nur77 showed almost complete loss of Ly6C Ϫ monocytes in blood, bone marrow, and spleen. 25 There has been a flurry of reports showing polarization of macrophages in response to tissue injury or infection. 26 -31 In many cases, there is probably a continuum of macrophage phenotypes; however, 2 primary phenotypes have emerged and are delineated as M1 or M2. M1 or classically activated macrophages typically are considered proinflammatory and produce interleukin (IL)-12, TNF␣, and nitric oxide. In contrast, M2 "alternatively activated" macrophages express distinct markers such as resistin-like molecule ␣ (RELM␣), CD301, CD206, Arginase-I, YM-1, and Fizz and may secrete IL-10 or VEGF, among others. Although Ly6C ϩ and Ly6C Ϫ monocytes can differentiate into either M1 or M2-like macrophages, several studies show that Ly6C ϩ monocytes tend to polarize toward a M1 phenotype in several models, 20, 22 whereas Ly6C
Ϫ monocytes tend to differentiate into M2-like macrophages. 32 These Ly6C
Ϫ monocyte-derived macrophages may be involved in resolution of inflammation and wound repair. Interestingly, a recent study indicates that in addition to recently recruited monocytes, macrophages that proliferate locally within tissues can also exhibit a M2 phenotype and control the inflammatory response. 33 In the current study, we examined the impact of loss of Ly6C Ϫ monocytes in Nur77 Ϫ/Ϫ mice on atherosclerosis development. We report that loss of Nur77 in hematopoietic cells enhances atherosclerosis development, most likely due to differential and enhanced macrophage polarization toward an M1 proinflammatory phenotype.
Methods
Detailed, expanded methods can be found online at http://circres.ahajournals.org. C57BL/6J wild-type (WT) mice (000664), ApoE Ϫ/Ϫ (002052), Ldlr Ϫ/Ϫ (002207), and Nur77
Ϫ/Ϫ mice on a congenic C57BL/6J background (006187) were from The Jackson Laboratory. Nur77 Ϫ/Ϫ mice were subsequently backcrossed onto the ApoE Ϫ/Ϫ background. Nur77 Ϫ/Ϫ and WT mice were used as donors for bone marrow transplants into Ldlr Ϫ/Ϫ recipients as described in the Online Supplement. Atherosclerosis was quantified in the aorta using en face analysis, aortic root analysis, and oil red O staining as described previously. 1,2
Results

Nur77 Deficiency in Bone Marrow-Derived Cells Increases Atherosclerosis
We examined atherosclerosis in ApoE Ϫ/Ϫ Nur77 Ϫ/Ϫ mice fed a Western diet for 11 weeks. ApoE Ϫ/Ϫ mice that were deficient in Nur77 showed a significant 4-fold increase in atherosclerosis development by en face staining of the aorta ( Figure 1A and 1B). We also observed a 2-fold induction in atherosclerotic lesion area in aortic roots of the apoE
Nur77
Ϫ/Ϫ mice ( Figure 1C ). Histological analysis of atherosclerotic lesions showed increased macrophage and lipid content in plaques from ApoE Ϫ/Ϫ Nur77 Ϫ/Ϫ mice compared with controls ( Figure 1D and 1E). Total cholesterol levels were not different between the 2 groups. There was a trend toward higher plasma triglyceride levels in apoE
Ϫ/Ϫ mice, but this did not reach statistical significance (Online Figure I) .
We previously reported that Nur77 Ϫ/Ϫ mice lack Ly6C Ϫ monocytes in vivo. 25 We confirmed loss of the Ly6C Ϫ monocyte subset in these double knockout mice on the ApoE Ϫ/Ϫ background. As expected, we found almost complete loss of Ly6C Ϫ monocytes in blood and spleens of ApoE Ϫ/Ϫ Nur77 Ϫ/Ϫ mice fed a Western diet ( Figure 2 ). In Nur77-deficient mice fed a Western diet, we observed a slight increase in Ly6C ϩ monocytes compared with WT; thus, due to the increase of this subset, overall total monocyte levels were not altered between the 2 groups after Western diet feeding (Figure 2 ). The T cell compartment was completely normal in Nur77 Ϫ/Ϫ mice (Online Figure II) as has been described. 34 In addition, no differences in numbers of B cells, granulocytes, or other immune cells were detected in blood from Nur77 Ϫ/Ϫ mice compared with controls after 11 weeks of Western diet feeding (Online Figure II) .
These findings led us to ask whether loss of Nur77 in bone marrow monocyte-derived cells contributes to the increased atherosclerosis observed in these mice. To address this question, we performed bone marrow transplant studies in which WT or Nur77-deficient (Nur77 Ϫ/Ϫ ) marrow was transplanted into atherosclerosis-susceptible Ldlr Ϫ/Ϫ mice. Mice were allowed to reconstitute the bone marrow compartment for 6 weeks and then were placed on a Western diet for 20 weeks. We observed a 3-fold increase in atherosclerosis development in mice that received Nur77 Ϫ/Ϫ bone marrow ( Figure 3) . We also observed a 3-fold increase in the amount of macrophages per aorta in mice that received Nur77 Ϫ/Ϫ bone marrow ( Figure 3C ). Thus, absence of Nur77 in bone marrow-derived cells contributes to atherogenesis and increased inflammatory macrophage content, despite the fact that these mice possess significantly fewer Ly6C 
Monocytes and Macrophages From Nur77
؊/؊
Mice Display a Proinflammatory Phenotype and Show Increased Lipid Accumulation
Based on our previous findings that Nur77 regulates the monocyte compartment in vivo, and based on the strong association of monocytes and macrophages with atherosclerosis, we focused the remaining aspects of our study on understanding how Nur77 regulates monocyte and macrophage function. First, we examined monocyte recruitment to tissues in vivo using a thioglycolate assay in the peritoneal cavity. We did not observe a difference in total populations of resident or thioglycolate-elicited peritoneal macrophages in Nur77 Ϫ/Ϫ compared with control mice, implying that there is not a major change in macrophage recruitment in the absence of Nur77 (Online Figure III) . Second, we examined the inflammatory responsiveness of Ly6C ϩ monocytes from WT and Nur77 Ϫ/Ϫ mice. Splenic CD115 ϩ CD11b ϩ cells were gated on Ly6C expression and sorted as described previously. 25 Monocytes were used untreated or were stimulated with LPS overnight. Expression of TNF␣ was quantified in the cells using FACS. Using TNF␣ protein expression as an indicator of inflammation, we observed that Ly6C ϩ monocytes from Nur77-deficient mice showed an exacerbated response to LPS ( Figure 4A ). To examine if this exaggerated LPS response in Ly6C ϩ monocytes could be possibly related to an absence of Nur77 in this subset, we examined the ability of WT Ly6C ϩ cells to upregulate NR4A family members in response to inflammatory stimuli and on adhesion-induced differentiation. As macrophages have previously been shown to rapidly upregulate NR4A family members in response to LPS, we confirmed this phenomenon in peritoneal macrophages (Online Figure IV) and determined that circulating Ly6C ϩ monocytes likewise upregulate Nur77 and NOR1, but not Nurr1, in response to LPS stimulation ( Figure 4B ). Thus, Nur77 is induced in Ly6C ϩ monocytes on inflammatory stimulation, which suggests that Nur77 has a function in the stimulated monocyte. As the inflammatory response is exacerbated in the Ly6C ϩ monocyte lacking Nur77, this suggests that at least one function of Nur77 in the activated Ly6C ϩ monocyte may be to resolve or control the inflammatory response of this cell during inflammation. In addition, monocytes adhere and will differentiate into macrophages when incubated on plastic. Using a new reporter transgenic mouse model 35 where induction of the Nr4a1 promoter drives green fluorescent protein (GFP) expression (Nur77-GFP), we previously observed that most CD11b ϩ F4/80 ϩ Ly6C Ϫ monocytes circulating in the blood and spleen of these reporter mice expressed abundant GFP expression, whereas most of the Ly6C ϩ monocytes expressed low levels of GFP. 25 We sorted GFP -CD11b ϩ Ly6C ϩ cells from this reporter mouse and incubated these monocytes on plastic to differentiate them into macrophages. As shown in Figure 4C , incubation of Ly6C ϩ cells on plastic caused a significant induction in GFP expression, suggesting that Nur77 expression is induced in macrophages on their differentiation and thus may be important for their normal function.
We next measured the ability of Ly6C ϩ monocytes to accumulate lipid. Ly6C ϩ monocytes isolated from Ldlr Ϫ/Ϫ recipients that had received Nur77 Ϫ/Ϫ bone marrow showed increased neutral lipid accumulation as measured by Nile red staining ( Figure 5A ). Ly6C ϩ monocytes lacking Nur77 showed a slight but significant increase in expression of scavenger receptor class A, member 1 (SR-A) but not CD36 ( Figure 5B ). Culturing the Ly6C ϩ monocytes overnight with DiI-oxidized low-density lipoprotein (OxLDL) resulted in increased uptake of OxLDL in the Nur77 Ϫ/Ϫ monocytes compared with WT ( Figure 5C ). Thus, Ly6C ϩ monocytes lacking Nur77 have enhanced cytokine production and enhanced uptake of OxLDL, indicating a proinflammatory phenotype.
We then examined the phenotypes of macrophages in these mice. We isolated resident macrophages from peritoneal lavage of 11-week Western diet-fed ApoE Ϫ/Ϫ and ApoE Ϫ/Ϫ Nur77 Ϫ/Ϫ mice (gating strategy, Online Figure  V ) and found enhanced expression of IL-12 and reduced expression of Arginase-I (ArgI) in ApoE Ϫ/Ϫ Nur77 Ϫ/Ϫ macrophages compared with ApoE Ϫ/Ϫ (WT) resident macrophages ( Figure 6A ). Stimulation of these macrophages from 11-week Western diet-fed mice for 2 hours with Kdo Lipid A (KLA), the active component of LPS, 36 caused further induction of IL-12, TNF, and iNOS in WT cells ( Figure 6A ). The IL-12 and iNOS expression in the stimulated macrophages was tripled in the absence of Nur77. ArgI expression remained lower in the ApoE
Nur77
Ϫ/Ϫ macrophages, even when treated with KLA. MHCII expression was significantly higher on peritoneal macrophages isolated from ApoE Ϫ/Ϫ Nur77 Ϫ/Ϫ mice compared with ApoE Ϫ/Ϫ (Figure 6B ), supporting the notion of increased macrophage activation in the absence of Nur77.
We also observed increased Dil-OxLDL uptake in bone marrow-derived macrophages cultured in GM-CSF from Nur77 Ϫ/Ϫ mice ( Figure 6C ). Finally, to confirm that macrophages in aorta of ApoE Ϫ/Ϫ Nur77 Ϫ/Ϫ mice showed a similar proinflammatory phenotype, F4/80 ϩ macrophages from aorta were analyzed for CD36, SR-A and TNF␣ expression. We observed a significant 2-fold induction of TNF␣, a 2.5-fold induction of SR-A, and a 5-fold induction of CD36 in ApoE Ϫ/Ϫ Nur77 Ϫ/Ϫ macrophages obtained from aorta ( Figure 6D ), supporting the presence of proinflammatory macrophages and increased lipid uptake in the aorta.
A recent study by Herzenberg et al 37 reported the presence of small versus large macrophages in the peritoneal cavity. Although Jenkins et al 33 have recently reported that macrophages can proliferate in tissue rather than necessarily being recruited from blood or spleen, many monocytes are indeed recruited to tissues in response to inflammatory stimuli. Small macrophages are thought to be derived from recruited Ly6C ϩ monocytes, whereas large macrophages tend to be the resident macrophages. In the peritoneal cavities of ApoE Ϫ/Ϫ Nur77 Ϫ/Ϫ mice, we found fewer large macrophages and more small macrophages (Online Figure VI) .
Abnormal Toll-Like Receptor Expression and NFB-Mediated Signaling in Nur77
؊/؊ Macrophages Interestingly, we found that expression of several toll-like receptors was increased in ApoE Ϫ/Ϫ Nur77 Ϫ/Ϫ macrophages fed chow and Western diets, particularly toll-like receptor (TLR)4 and TLR9 ( Figure 7A ). Concomitant with increased TLR4 mRNA expression, we found increased TLR4 surface protein expression in macrophages from ApoE Ϫ/Ϫ mice lacking Nur77 by FACS ( Figure 7B ). Nur77-deficient macrophages also showed increased expression of IL-12, and iNOS mRNA after 2 hours of KLA incubation in vitro ( Figure 7C ). There was a small increase in TNF␣ expression although it was not significant. These data point to polarization of macrophages toward a M1 phenotype in the absence of Nur77. Moreover, Nur77-deficient macrophages exhibited a blunted "M2-like" response, with low baseline expression of ArgI, and little induction of ArgI expression in response to KLA treatment ( Figure 7C ). Similarly, Nur77-deficient macrophages showed enhanced responsiveness to TLR agonists, including the TLR4 agonist KLA, the TLR2 agonist Pam 3 CSK4, and the TLR7 agonist R-848 ( Figure 7D ). Treatment with these TLR agonists uniformly increased TNF␣, IL-12, and nitric oxide production ( Figure 7D ). We also discovered that, similar to what we previously reported for monocytes, Nur77-deficient macrophages had increased phosphorylation of the p65 subunit of NFB, suggesting enhanced activation of NFB ( Figure 7E ). Phosphorylation of p65 helps stabilize NFB in the nucleus for gene transcription. 39, 40 To determine if the enhanced inflammatory signaling in Nur77-deficient macrophages is NFBdependent, we conducted similar peritoneal macrophage activation experiments in the presence of the NFB inhibitor BAY11-7082 (BAY), which selectively and irreversibly inhibits NF-B activation by blocking phosphorylation and degradation of IB-␣. The increased inflammatory activity observed in the Nur77-deficient macrophages was ablated by BAY-mediated inhibition of NF-B ( Figure 7F and 7G) . Thus, Nur77-deficient macrophages show enhanced NFBdependent inflammatory activation.
Human CD14 dim
CD16
؉ Monocytes Express Nur77
Three distinct subsets of human monocytes have been identified, based on their surface markers:
ϩ CD16 ϩ , and CD14 dim CD16 ϩ ( Figure 8A ). Murine Ly6C ϩ monocytes are analogous to CD14 ϩ monocytes in humans, which exhibit a strong inflammatory response to LPS, and Ly6C Ϫ mouse monocytes are most analogous to CD14 dim CD16 ϩ human monocytes, which patrol blood vessels. 11 The physiological function of the newly identified CD14 ϩ CD16 ϩ subset is unclear. 11, 40 We quantified Nur77 mRNA expression in these 3 human monocytes subsets using real-time PCR and found a pattern of expression similar to what we observe in the mouse. 25 CCL3 is highly expressed in CD14 hi monocytes and is shown here as a control for separation of the subsets. Expression of NR4A1 is quite high in CD14 dim CD16
ϩ human monocytes, the counterpart to patrolling Ly6C Ϫ monocytes in mice ( Figure 8B ). Nur77 was expressed in CD14 ϩ CD16 ϩ human monocytes, but at much lower levels. In contrast, Nur77 was barely detectable in the CD14 ϩ subset (analogous to Ly6C ϩ monocytes in mice). Thus, Nur77 probably plays a functional role in the CD14 dim CD16 ϩ monocyte subset in humans under basal conditions, similar to mice.
Discussion
The NR4A family of nuclear receptors plays an important role in inflammation and vascular injury. 3, 4 Although studies have shown that NOR-1 is important in atherogenesis, 8, 9 the role of Nur77 in atherogenesis has remained unclear. We recently reported a role for Nur77 in regulating monocyte development, 25 and others have reported a role for NR4A family members in regulating inflammatory responses in macrophages and microglia. [5] [6] [7] In the current study, we show that mice deficient in Nur77 display greater atherosclerosis development than do control mice when fed a Western diet. Our data indicate that this is associated with (1) a lack of Ly6C Ϫ patrolling monocytes and (2) enhanced polarization of Ly6C ϩ monocytes and derived macrophages toward a proinflammatory M1-like phenotype, which may be responsible for exacerbated lesion development. How enhanced M1 polarization is related to loss of Ly6C Ϫ monocytes remains to be elucidated.
Based on our prior work that showed the almost complete loss of Ly6C Ϫ monocytes in Nur77 Ϫ/Ϫ bone marrow, blood, and spleen, 25 one hypothesis is that the increased macrophage activation and phenotypic proinflammatory M1 polarization of macrophages in Nur77 Ϫ/Ϫ mice is due to loss of this protective Ly6C
Ϫ monocyte subset. Lack of this subset may impair the resolution of inflammation and would lead to enhanced proinflammatory signaling in macrophages, thus Ϫ/Ϫ mice and C57BL/6J wild-type control (WT) mice on chow diet, unstimulated (UN), or stimulated for 2 or 24 hours with 30 g/mL KLA (right) measured by quantitative real-time PCR. Quantification of data expressed as percent change in mRNA over untreated WT expression for each gene; *PϽ0.001. D, TNF␣, IL-12, and nitric oxide production by peritoneal macrophages from Nur77 Ϫ/Ϫ mice and C57BL/6J wild-type control (WT) mice on chow diet, unstimulated (UN) or stimulated for 18 hours with either 30 g/mL KLA, 5 g/mL R848, or 30 ng/mL PAM2. TNF␣ and IL-12 proteins were measured by ELISA, and nitric oxide was measured by the Griess assay. *PϽ0.001. E, Intracellular staining of p65 activation in peritoneal macrophages from Nur77 Ϫ/Ϫ mice and C57BL/6J wild-type control (WT) mice on chow diet unstimulated (UN) or stimulated for 2 hours with either 30 g/mL KLA by flow cytometry using a p65 phosphoserine 529 (pS529) antibody. Data are representative of 2 independent experiments. F, IL-12, iNOS, and TNF␣ mRNA expression in peritoneal macrophages from Nur77 diminishing an M2-like inflammatory response by macrophages. A second possibility for the observed inflammatory macrophage phenotype is that Ly6C ϩ monocytes from Nur77 Ϫ/Ϫ mice may give rise to a more proinflammatory activated M1-like macrophage phenotype, suggesting that Nur77 plays a cell-autonomous role in regulating the inflammatory responsiveness of the Ly6C ϩ monocyte subset. This scenario would be independent of any regulation or suppression by Ly6C Ϫ monocytes. In support of this concept is the fact that Nur77, although highly expressed in Ly6C Ϫ monocytes, is also present in Ly6C ϩ monocytes, 25 particularly on their activation ( Figure 4B ). Therefore, Nur77 probably becomes important in activated monocytes and macrophages in a cell-autonomous manner to keep the inflammatory process in check. In the absence of a Nur77-mediated negative feedback mechanism, these macrophages appear to be somewhat constitutively activated and hypersensitive to inflammatory stimuli. However, we cannot rule out an important role solely for the Ly6C Ϫ monocyte subset in resolving the inflammatory response in vivo, particularly in that the known function of this subset is to patrol the vasculature in search of pathogens. This subset could act to directly dampen an inflammatory response that is mediated by the Ly6C ϩ subset in vivo. Future studies will hopefully allow us to discern the roles of each of these monocyte subsets on atherogenesis as well as to define how Nur77 influences the function of each subset.
In the current study, we observed increased inflammatory activities mediated via activation of the NFB and TLR signaling pathways in Nur77 Ϫ/Ϫ macrophages, which are blocked by NFB inhibitors (Figure 7) . We do not find any evidence of Nur77 activation of NFB signaling by induction of IKK expression as has been reported by Pei et al. 41 The studies from Pei et al were Nur77 overexpression studies performed in macrophage cell lines and not in primary cells or in vivo, which may partially explain the differing results. As of yet, we do not know the exact mechanisms for how NR4A1 functions in these cells to regulate NFB. We believe the increased inflammatory activity is at least partially due to the absence of Nur77's ability to produce the NFB inhibitory protein, IB-␣, as we report in monocytes and others have reported in cell lines. 26, 42 Nur77 has been demonstrated to positively regulate expression of IB-␣ via a defined and functional Nur77 response element in the IB-␣ promoter. 42 Glass et al 7 have also previously shown that another NR4A family member, Nurr1, inhibits NFB through the recruitment of corepressor CoREST complexes, in microglia. This Nurr1-CoREST negative feedback loop results in NFB turnover and loss of activated gene expression. Whether Nur77 interacts with CoREST in macrophages is currently unknown. Additionally, the ability of Nur77 to heterodimerize with other nuclear receptors such as RXR allows for varying cellular responses and probably will make the underlying mechanism of Nur77 regulation of NFB and other proinflammatory transcription factors more difficult to discern.
As a transcription factor, Nur77 functions to regulate many cellular processes, including cell growth, activation, proliferation, and apoptosis. 1,4,43 TLR-mediated NFB signaling is one of several pathways that may be modulated by this nuclear receptor. Increased NFB activity in the absence of the Nur77 probably induces expression of a number of proinflammatory cytokines due to the loss of ؉ human monocytes express high levels of Nur77. Monocytes were isolated from human blood of normal donors and monocytes isolated by cell sorting using CD14 and CD16 antibodies. A, Representative scatterplot of human blood monocyte populations based on CD14 and CD16 expression. B, Quantification of mRNA expression for CCL3 and Nur77 in the 3 human monocyte subsets. ***PϽ0.0001 by ANOVA. Nur77 transrepression. Indeed, studies have suggested that Nur77 negatively regulates several cytokines that may be important in inflammation. 44 -46 Previous studies have demonstrated that Nur77 expression inhibits SR-A and CD36 expression to reduce lipid loading in cultured macrophages, implying a role in regulating lipid uptake. 46 We confirm this important role of Nur77 in regulating lipid uptake by demonstrating increased scavenger receptor expression and lipid uptake in macrophages in the absence of Nur77 in vivo. We also find a role for Nur77 in regulating SR-A expression and lipid uptake in monocytes. Interestingly, we did not observe variation of CD36 expression in monocytes as we did in macrophages. One possible explanation of this result is that there may be differential regulation of these scavenger receptors in monocytes versus macrophages. In fact, it has been demonstrated that CD36 is strongly upregulated with monocyte to macrophage differentiation and M-CSF stimulation. 47 In addition, Nur77 can function to directly induce expression of anti-inflammatory genes. One example of this is that Nur77 has been shown to induce ABCA1, a protein involved both in cholesterol efflux and macrophage inflammation. 41, 48, 49 ArgI is a well-known marker of macrophage polarization whose expression is increased in antiinflammatory M2 macrophages. As such, we find reduced expression of ArgI in Nur77 Ϫ/Ϫ macrophages ( Figure 7) . Analysis of the murine ArgI promoter using Jaspar and MacVector software packages revealed the presence of 8 putative Nur77 NBRE elements and one NBRE:RXR element located within a 3-kb fragment upstream of the transcriptional start site of the murine ArgI gene (data not shown). Thus, Nur77 may directly regulate ArgI transcription, either alone or through RXR dimerization, which would directly impact the polarization of macrophages.
We focused on macrophages in this study because of our recent finding that Nur77 regulates monocyte development. In the current study, we find increased macrophage inflammation in atherosclerotic plaques of Nur77 Ϫ/Ϫ mice, confirming the importance of Nur77 in regulating inflammatory events in myeloid cells. However, Nur77 also influences T cell receptor affinity, 35 thereby possibly regulating T cell activation or even thymocyte selection. Several groups have implicated Nur77 in thymocyte selection, 50, 51 although the Nur77 Ϫ/Ϫ mouse shows normal T cell development. 34 We observed no obvious differences in numbers of circulating T cells or other immune cells in Nur77 Ϫ/Ϫ mice fed a Western diet (Online Figure II) , implying that the increase in atherosclerosis is probably myeloid cell-specific. Furthermore, under normal conditions Nur77 is most highly expressed in Ly6C Ϫ monocytes, with little expression in other immune cell types. 25, 35 Nur77 may be upregulated in lymphocytes including T cells, NKT, and T regs with antigen stimulation but not with inflammatory stimuli, implying that there might not be a major role of Nur77 in T cell-mediated inflammation. 35 Although our results clearly point to a critical role for Nur77 in monocytes and macrophages, we cannot definitively rule out a role for Nur77 in T cells or other immune cells on atherosclerosis development. The use of conditional knockout mice will be important to delineate the roles of lymphocyte versus myeloid-selective Nur77 functions in atherogenesis.
The fact that we observed high expression of Nur77 in CD14 dim human monocytes, the equivalent to the Ly6C Ϫ patrolling monocyte subset in mice, suggests a unique function for Nur77 in this human monocyte subset. Polymorphisms in NR4A1 that change Nur77 expression could be important for both acute and chronic inflammatory responses in human disease. Several SNPs have been reported for the human NR4A1 gene and several of these are located within the known promoter region of the gene. 52 Future studies of these polymorphisms in population studies will be important for determining whether therapies targeting Nur77 expression could be effective for inflammatory diseases. In summary, we have identified that absence of Nur77 in hematopoietic cells amplifies atherosclerosis development in mice. Our data suggest that Nur77 functions to regulate macrophage phenotypes in vivo and that absence of Nur77 in macrophages skews the profile of macrophages toward a proinflammatory, proatherogenic phenotype.
While this article was under review, a similar study by Hamers et al. was presented to Circulation Research and has also been accepted for publication. In accordance with our data, the group of C.J.M. de Vries demonstrated that absence of Nur77 in bone marrow-derived cells increased atherosclerosis. Together, our 2 studies support a protective role for Nur77 in hematopoietic cells in atherogenesis.
